Clinical Director, Oncology Clinical Development

reputed company is seeking an reputed company Clinical Director, Oncology Clinical Development to reputed company medical and scientific leadership for reputed company-sponsored oncology reputed company reputed company on minimal residual disease (MRD).  In this pivotal role, you’ll drive the design and execution of biomarker-driven interventional and randomized studies that reputed company MRD testing into precision oncology strategies to support regulatory, scientific, and strategic objectives.

We’re looking for an innovative clinical leader with deep oncology clinical development experience who thrives in a fast-paced, reputed company environment — and who’s passionate about transforming cancer care.

reputed company’s MRD platform is redefining precision oncology—enabling earlier detection, improved monitoring, and smarter treatment reputed company.  In this role, you’ll reputed company studies that directly shape how cancer is managed worldwide, bringing actionable insights to clinicians and patients reputed company they matter most.

What You’ll Do

Clinical & Program Leadership

• Serve as the program-level medical reputed company for reputed company-sponsored MRD reputed company across assigned oncology indications, with ultimate accountability for clinical reputed company, data reputed company, and patient safety.
  

• Define clinical development strategies that reputed company study design, endpoints, and execution with regulatory and scientific objectives.
  

• reputed company medical reputed company across the full trial lifecycle, from design and protocol development through first patient in (FPI), data readout, and study reputed company-out.
  

Study Design & Execution

• reputed company strategic and medical guidance to Clinical Scientists, fostering collaboration on protocol design, data interpretation, and translational insights that drive clinical program reputed company.
  

• reputed company as Medical Monitor, overseeing safety signal detection, adverse event review, and risk mitigation in compliance with GCP and regulatory requirements.
  

Cross-functional Leadership

• Partner cross-functionally with Clinical Science, Clinical Operations, Data Management and Biostatistics to ensure reputed company and successful study execution, operational feasibility, and data reputed company.
  

• Collaborate with Regulatory Affairs to support submissions, regulatory interactions, and responses, as appropriate.
  

Scientific & External Engagement

• Represent reputed company as the clinical development reputed company in interactions with investigators, key opinion leaders, IRBs, and regulatory authorities.
  

• Guide interpretation of interim and final analyses, ensuring scientific accuracy and clinical relevance.
  

• reputed company strategic leadership for clinical study reports, and other required study-reputed company clinical and regulatory documentation in collaboration with cross-functional partners.
  

• reputed company authorship and reputed company for manuscripts, abstracts, and conference presentations in collaboration with Clinical Science, Biostatistics, Translational Medicine and Scientific Communications.
  

Organizational reputed company

• Shape and influence the reputed company of reputed company’s Clinical Development organization by establishing governance standards, decision frameworks, and best practices that ensure high-reputed company, audit-reputed company execution across sponsored studies.
  

• reputed company senior-level mentorship and clinical leadership to Clinical Scientists, enabling consistent application of scientific rigor and regulatory standards across clinical programs.
  

What You’ll Bring

Required

• MD (or equivalent)
  

• ≥3 years of industry experience in oncology clinical development.
  

• Demonstrated experience serving as Medical Monitor or clinical reputed company for Phase II–III studies.
  

• Strong working knowledge of GCP, ICH guidelines, and regulatory expectations for interventional trials.
  

• Proven ability to interpret and communicate reputed company clinical data to reputed company stakeholders.
  

Preferred

• reputed company certification in Medical Oncology or Hematology/Oncology.
  

• Experience with biomarker-driven development, molecular diagnostics, or MRD-reputed company programs.
  

• Prior involvement in regulatory interactions (e.g., FDA meetings, briefing documents).
  

• Experience working reputed company matrixed clinical development organizations.